Pharming Group Nv share price logo

Pharming Group Nv Share Price

NASDAQ: PHAR

Small Cap

$16.07

-0.24

(-1.47%)

as on

Pharming Group Nv Stock Performance

as on March 28, 2026 at 6:55 am IST

  • Day's Low

    Day's High

    $15.69
    $16.43
    downward going graph

    2.36%

    Downside

    2.24%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.50
    $21.34
    downward going graph

    53.32%

    Downside

    32.79%

    Upside

    downward going graph

Pharming Group Nv share price movements today

Previous Close
$16.31
Open
$16.16
Volume
159.0K
Day's Low - High
$15.69 - $16.43
52 Week Low - High
$7.50 - $21.34

Pharming Group Nv Historical Returns

1 Month Return
+ 0.06 %
3 Month Return
-8.37 %
1 Year Return
+ 96.27 %
3 Year Return
+ 28.43 %
5 Year Return
+ 25.75 %

Pharming Group Nv Stock Fundamentals & Key Indicators

Check Pharming Group Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

0.0345

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.98%

PE Ratio (TTM)

407.75

Industry PE ratio

0

PEG Ratio

0

EBITDA

43.5M

Revenue (TTM)

376.1M

Profit Margin

0.76%

Return On Equity TTM

1.02%

Pharming Group Nv Stock Valuation

Track how Pharming Group Nv P/E has moved over time to understand its valuation trends.

Pharming Group Nv in the last 5 years

  • Overview

  • Trends

Lowest (-179.29x)

March 31, 2025

Industry (0.00x)

March 28, 2026

Today (407.75x)

March 28, 2026

Highest (133.92x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 407.75x

Pharming Group Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group Nv with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Pharming Group Nv image
Pharming Group Nv
BUY$1.1B25.75%407.750.76%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.5B132.92%140.848.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.2B101.77%29.5832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.8BNA112.585.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.0B54.69%18.2531.41%

Stock Returns calculator for Pharming Group Nv Stock including INR - Dollar returns

The Pharming Group Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharming Group Nv investment value today

Current value as on today

₹2,04,009

Returns

₹1,04,009

(+104.01%)

Returns from Pharming Group Nv Stock

₹93,381 (+93.38%)

Dollar Returns*

₹10,628 (+10.63%)

Analyst Recommendation on Pharming Group Nv Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Pharming Group Nv. Average target price of $33.8

Pharming Group Nv Share Price Target

Get share price movements and forecasts by analysts on Pharming Group Nv.

What analysts predicted

52.46%UPSIDE

Target Price

$33.8

Current Price

$16.07

Analyzed by

14 Analysts

Target

$33.80

Pharming Group Nv target price $33.8, a slight upside of 52.46% compared to current price of $16.07. According to 14 analysts rating.

Pharming Group Nv Stock’s Investor Sentiment and Interest

Search interest for Pharming Group Nv Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-29% versus previous 30 day period

Pharming Group Nv Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
66
81
55
74
74
92,700
79
93
97
90
Gross Profit
58
74
47
66
68
80,500
70
84
90
72
Operating Income
1
0
-16
-3
4
6,600
-7
10
15
1
EBITDA
4
8
-9
-4
7
-
-4
9
23
6,203
Interest Expense
1
4
1
1
2
-
5
0
7
1,400
Depreciation
2
7
5
0
2
7
2
2
2
3
Income Before Tax
3
-2
-16
0
1
6,700
-11
7
12
4
Income Tax Expense
0
0
-4
1
2
-
3
2
5
0
Net Income
3
-2
-12
-1
-1
2,900
-14
4
7
4
Net Profit Margin
5.20%
-3.33%
-22.39%
-1.62%
-1.38%
3.13%
-18.61%
5.04%
7.76%
4.98%

Pharming Group Nv Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
16
107
154
189
212
198
205
245
297
321
Gross Profit
11
92
129
165
188
177
188
220
261
282
Operating Income
-12
26
43
68
76
13
18
-5
-8
16
EBITDA
-13
-39
50
71
58
48
33
9
16
26
Interest Expense
3
21
16
13
10
6
5
5
8
18
Depreciation
-
3
6
5
7
16
13
15
16
11
Income Before Tax
-18
-107
0
52
44
23
14
-12
-8
10
Income Tax Expense
3
-11
-27
11
6
7
1
-1
3
8
Net Income
-18
-95
28
40
37
15
13
-10
-11
2
Net Profit Margin
-110.48%
-89.22%
18.50%
21.41%
17.79%
8.04%
6.65%
-4.30%
-3.98%
0.76%

Pharming Group Nv Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-2
-16
-1
-1
3
-11
7
7
4
Operating Cash Flow
12
-7
-13
9
9
0
11
30
6
Investing Cash Flow
-
0
36
4
-
9
16
-2
0
Financing Cash Flow
-1
-2
-28
-1
-2
-6
-2
11
3
Change in Cash
6
-9
-4
13
-2
5
31
38
11

Pharming Group Nv Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
26
43
52
44
23
14
-12
-8
2
Operating Cash Flow
45
46
74
83
37
22
-17
-1
42
Investing Cash Flow
-7
-4
-28
-15
-21
5
-129
31
15
Financing Cash Flow
-3
-20
-63
60
-27
-4
-1
-34
12
Change in Cash
33
24
-17
130
-13
15
-145
-6
77

Global Institutional Holdings in Pharming Group Nv

Funds
Holdings
Goss Wealth Management LLC
0.04%
Bessemer Group Inc
0%
Millennium Management LLC
0.03%
Coldstream Capital Management Inc
0%
SBI Securities Co Ltd
0%
See all

Insights on Pharming Group Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, PHAR stock has moved up by 96.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PHAR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.0% return, outperforming this stock by 42.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 97.28M → 90.57M (in $), with an average decrease of 6.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 7.54M → 4.50M (in $), with an average decrease of 40.3% per quarter

About Pharming Group Nv

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
OrganisationPharming Group Nv
HeadquartersDarwinweg 24, Leiden, Netherlands, 2333 CR
CEOMr. Fabrice Chouraqui Ph.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Pharming Group Nv

Name

Title

Dr. Anurag Relan M.D., MPH

Chief Medical Officer

Dr. Alexander Breidenbach M.B.A.

Chief Business Officer

Mr. Fabrice Chouraqui Ph.D., Pharm.D.

CEO & Executive Director

Mr. Kenneth Lynard EMBA

Chief Financial Officer

Ms. Mireille Sanders M.Sc.

Chief Operations Officer

Ms. Susanne Embleton

Investor Relations Manager

Mr. Ruud Van Outersterp

Chief Legal & Compliance Officer

Ms. Ines Bernal

Chief People Officer

Mr. Michael K. Levitan

VP of Investor Relations & Corporate Communications

Ms. Leverne Marsh

Chief Commercial Officer

FAQs

What is Pharming Group Nv share price today?

Pharming Group Nv share price today is $16.07 as on at the close of the market. Pharming Group Nv share today touched a day high of $16.43 and a low of $15.69.

What is the 52 week high and 52 week low for Pharming Group Nv share?

Pharming Group Nv share touched a 52 week high of $21.34 on and a 52 week low of $7.5 on . Pharming Group Nv stock price today i.e. is closed at $16.07,which is 24.70% down from its 52 week high and 114.22% up from its 52 week low.

What is Pharming Group Nv's market capitalisation today?

Pharming Group Nv market capitalisation is $0.00T as on .

How to invest in Pharming Group Nv Stock (PHAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharming Group Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group Nv Shares that will get you 0.0933 shares as per Pharming Group Nv share price of $16.07 per share as on March 28, 2026 at 1:25 am IST.

What is the minimum amount required to buy Pharming Group Nv Stock (PHAR) from India?

Indian investors can start investing in Pharming Group Nv (PHAR) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Pharming Group Nv stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharming Group Nv share’s latest price of $16.07 as on March 28, 2026 at 1:25 am IST, you will get 0.6223 shares of Pharming Group Nv. Learn more about fractional shares .

What are the returns that Pharming Group Nv has given to Indian investors in the last 5 years?

Pharming Group Nv stock has given 25.75% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?